Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation.
Imane Abou DalleHagop M KantarjianSarah A BannonRashmi Kanagal-ShamanaMark RoutbortKeyur P PatelShimin HuKapil BhallaGuillermo Garcia-ManeroCourtney D D DiNardoPublished in: American journal of hematology (2019)